Table 3 Significant results of the follow-up analysis in the acute lymphoid leukemia population
Gene | SNP | Genotype group 1 / group 2 | Mean FS % ± SE genotype group 1 (N) | Mean FS % ± SE genotype group 2 (N) | P value | Follow-up category |
|---|---|---|---|---|---|---|
ABCB1 | rs9282564 | AA / AG + GG | 41.5 ± 0.7 (100) | 37.9 ± 1.1 (29) | 2 .50E-03 | 10–15 years after Dx |
ABCC1 | rs35626 | GG / GT + TT | 41.0 ± 0.6 (92) | 39.0 ± 0.6 (127) | 7 .90E-03 | 2–5 years after Dx |
ABCC2 | rs3740066 | GG / GA / AA | 39.5 ± 0.5 (112) | 40.8 ± 0.5 (112) / 42.9 ± 0.9 (33) | 4 .50E-03 | 5–10 years after Dx |
NQO1 | rs1043470 | CC / CT + TT | 40.9 ± 0.5 (198) | 38.1 ± 0.9 (53) | 2 .60E-03 | acute phase |
SLC22A6 | rs6591722 | TT + TA / AA | 40.7 ± 0.4 (227) | 37.8 ± 1.0 (28) | 5 .90E-03 | 5–10 years after Dx |
SLC28A3 | rs7853758 | GG / GA + AA | 41.3 ± 0.7 (96) | 38.4 ± 1.1 (36) | 4 .80E-03 | 10–15 years after Dx |
SLC28A3 | rs885004 | GG / GA + AA | 41.3 ± 0.7 (95) | 38.0 ± 1.1 (33) | 2 .50E-03 | 10–15 years after Dx |